series-c-plus
Stage
2
Investors
About
Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments to reverse or prevent blindness from inherited retinal diseases, with ongoing Phase I/II clinical trials for X-linked retinoschisis and Leber congenital amaurosis type 1.
Explore atsena therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.